Full Description
Plaquex® Oral gelcaps are for the following indications:
- Hypercholesterolaemia
- Hyperlipoproteinaemia
- Liver Disease
- Suboptimal Blood Rheology
- Diminished creatinine and urea clearance
- Gastric side effects of NSAID usage
Plaquex® Oral lowers LDL and triglycerides and increases HDL. It also improves blood flow and liver function. It’s main ingredient is polyenylphosphatidylcholine. Phosphatidylcholine (PC) is the building block of cell membranes and transport vessels for blood lipids. The action of PC in many studies was reflected in an increase of HDL cholesterol and a decrease in LDL cholesterol, VLDL triglycerides as well as reduced ratio of LDL/HDL cholesterol. The main reason being that the transport vessels had an increased capacity for LDL and HDL up take in their cell membranes. The administration of phosphatidylcholine also results in a decrease in aortic lipid peroxidation products, but also in an increase in glutathione levels in the liver, plasma and aortic tissue. The glutathione-dependent antioxidative capacity in the aortic wall was found to increase markedly. Plaquex Oral is indicated for lowering cholesterol levels, triglyceride levels and to improve liver function but also as a additional treatment to Plaquex infusions to prevent renewed plaque build-up in the blood vessels after removal. In addition it was shown that oral PC can improve creatinine and urea clearance in patients with kidney disease
Usage Directions
Serving size: 1 softgel
Amount per serving: 900 mg Polyenylphosphatidylcholine [Unsaturated phosphatidylcholine from highly purified soy bean (Glycine max) extract]
Other ingredients: gelatin, glycerin, safflower oil, ethanol, purified water, sunflower glycerides. Contains soybeans
Each bottle contains 60 softgels x 900 mg